Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142611 |
| CAS No | NA |
| Mol.F. | C14H18Cl2N2O2 |
| Mol.Wt. | 317.21g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142612 |
| CAS No | NA |
| Mol.F. | C18H27N3O2 |
| Mol.Wt. | 317.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142613 |
| CAS No | NA |
| Mol.F. | C15H21N3O2 |
| Mol.Wt. | 275.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142614 |
| CAS No | NA |
| Mol.F. | C15H20ClN3O2 |
| Mol.Wt. | 309.79 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142615 |
| CAS No | NA |
| Mol.F. | C16H23ClN3O2 |
| Mol.Wt. | 324.83 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142616 |
| CAS No | NA |
| Mol.F. | C18H26BrN3O2 |
| Mol.Wt. | 396.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142617 |
| CAS No | NA |
| Mol.F. | C18H26ClN3O2 |
| Mol.Wt. | 351.88 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142618 |
| CAS No | NA |
| Mol.F. | C18H27N3O2 |
| Mol.Wt. | 317.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142619 |
| CAS No | NA |
| Mol.F. | C16H23N3O2 |
| Mol.Wt. | 289.38 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142620 |
| CAS No | NA |
| Mol.F. | C17H25N3O2 |
| Mol.Wt. | 303.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142621 |
| CAS No | NA |
| Mol.F. | C18H27N3O3 |
| Mol.Wt. | 333.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142622 |
| CAS No | NA |
| Mol.F. | C5H7N3O2S |
| Mol.Wt. | 173.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142623 |
| CAS No | NA |
| Mol.F. | C11H9ClN6O2S |
| Mol.Wt. | 324.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142624 |
| CAS No | NA |
| Mol.F. | C11H9ClN6O2S |
| Mol.Wt. | 324.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142625 |
| CAS No | NA |
| Mol.F. | C9H6ClN7O2S |
| Mol.Wt. | 311.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142626 |
| CAS No | NA |
| Mol.F. | C12H15ClN2O3 |
| Mol.Wt. | 270.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |